ASP Isotopes Inc. (ASPI) Stock Analysis 2026

Basic MaterialsSpecialty Chemicals

BriMind AI Score

Proprietary
24
Weak
Price CAGR
-0.6%
1Y Return
-74.2%
Analyst Upside
+398.3%
Rev Growth
327.6%

Score based on historical price CAGR, revenue growth, analyst upside, and valuation factors. Updated daily.

AI scores and price targets are for informational and educational purposes only. They do not constitute financial advice or a recommendation to buy or sell any security. Past performance is not indicative of future results. Always conduct your own research before making investment decisions. Full Disclaimer →

ASPI Revenue & Profitability Breakdown

This chart shows how ASPI's revenue flows through to profit. Each row deducts a layer of costs: first the direct cost of making products/services (Cost of Revenue), then operating expenses like marketing and R&D, then taxes. What remains at the bottom is net income — the actual profit shareholders own. High gross and net margins indicate a business with strong pricing power and efficiency.

Revenue
$30.9M
Cost of Revenue
-$25.2M
Gross Profit
$5.7M18.3% margin
Operating Expenses
-$5.7M
Operating Income
$0-667.5% margin
Net Income
$00.0% margin
Gross Margin
18.3%
Operating Margin
-667.5%
Net Margin
0.0%

Key Financial Metrics

ASP Isotopes Inc. doesn't carry a meaningful trailing P/E right now, generates $-28.6M in free cash flow, runs a debt/equity ratio of 98.09, and converts shareholder equity into profit at a -90.3% return on equity. For context: P/E ratio measures how much you pay for $1 of earnings (lower = cheaper, but fast-growing companies command higher P/E); Free Cash Flow is the cash left after running the business; Debt/Equity shows how leveraged a company is; Return on Equity shows how efficiently it turns shareholder capital into profit.

Market Cap
$507.5M
P/E (Forward)
-2.85
Price / Book
1.63
Revenue
$30.9M
Revenue Growth
327.6%
EPS (Trailing)
$-1.44
EPS (Forward)
$-1.16
Gross Margin
18.3%
Operating Margin
-667.5%
Net Margin
0.0%
Return on Equity
-90.3%
Return on Assets
-17.0%
Free Cash Flow
$-28.6M
Debt / Equity
98.09
Current Ratio
3.87
Quick Ratio
3.69
Beta
3.60
Dividend Yield
None
Payout Ratio
0.0%
Insider Ownership
10.5%
Inst. Ownership
48.1%
Short % Float
18.2%
Book Value / Share
$2.03

Wall Street Analyst Consensus

Wall Street analysts covering ASP Isotopes Inc. currently haven't converged on a clear consensus rating, with a mean 12-month price target of $13.00. Analysts set these targets after researching a company's earnings, competitive position, and industry trends — Strong Buy / Buy means the majority expect meaningful upside, while Hold means fair value near the current price rather than a sell signal.

Mean Target$13.00

Technical Price Signals

ASPI is currently in a mixed technical position. Moving averages smooth out day-to-day volatility to reveal the underlying trend — a Golden Cross (50MA crosses above 200MA) is a classic bullish signal, a Death Cross is bearish, though both are lagging indicators that confirm trends rather than predict them.

50-Day MA
$4.19
200-Day MA
$5.48

More Basic Materials Stock Analysis

In-depth reports on companies operating alongside ASPI — business models, bull and bear cases, and the metrics that matter.

SHWThe Sherwin-Williams CompanySpecialty ChemicalsPPGPPG Industries, Inc.Specialty ChemicalsESIElement Solutions IncSpecialty ChemicalsECLEcolab Inc.Specialty ChemicalsCLFCleveland-Cliffs Inc.SteelAAAlcoa CorporationAluminumSTLDSteel Dynamics, Inc.SteelCRHCRH plcBuilding Materials

Unlock the Full ASPI Analysis

Interactive price charts, real-time AI signals, advanced DCF models, portfolio tracking, earnings analysis, and side-by-side peer comparisons. Start your 14-day free trial — no credit card required.

Start Free TrialBrowse All Stocks
Data sources: Financial metrics and market data sourced from company SEC filings, earnings releases, and investor relations disclosures. Price data, analyst consensus targets, and fundamental financials provided by financial market data providers. ETF data sourced from official fund prospectuses and index provider publications. AI scores and price targets are proprietary estimates — see our Methodology and Disclaimer for details.
← Back to Home · Browse All Stock Analysis